Old Web
English
Sign In
Acemap
>
authorDetail
>
Deepika Parimoo
Deepika Parimoo
University of Southern California
Paclitaxel
Pharmacology
Medicine
Immunology
Chemotherapy
5
Papers
41
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CBCT Evaluation of Residual Dentin Thickness
2016
Deepika Parimoo
Annil Dhingra
Sahil Rohilla
Show All
Source
Cite
Save
Citations (0)
Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors.
1999
Cancer Chemotherapy and Pharmacology
Robert T. Koda
Agustin A. Garcia
Dhruba J. Chatterjee
Wen Yen Li
Deepika Parimoo
Susan Jeffers
Marion Rogers
C. Gail Leichman
Lawrence Leichman
Ellen Y. Wu
Bhasker V. Shetty
Stephanie Webber
Neil Clendinnin
Franco M. Muggia
Show All
Source
Cite
Save
Citations (0)
Phase I and pharmacologic study of estramustine phosphate and short infusions of paclitaxel in women with solid tumors.
1998
Journal of Clinical Oncology
Agustin A. Garcia
S. Keren-Rosenberg
Deepika Parimoo
M. Rogers
Susan Jeffers
Robert T. Koda
Franco M. Muggia
Show All
Source
Cite
Save
Citations (9)
Tolerance of paclitaxel 3-hour infusion with and without granulocyte colony-stimulating factor on a biweekly schedule
1997
Seminars in Oncology
Agustin A. Garcia
Deepika Parimoo
I. Dimery
M. Rogers
Susan Jeffers
Franco M. Muggia
Show All
Source
Cite
Save
Citations (3)
Severe Neurotoxicity From Vinorelbine-Paclitaxel Combinations
1996
Journal of the National Cancer Institute
Deepika Parimoo
Susan Jeffers
Franco M. Muggia
Show All
Source
Cite
Save
Citations (29)
1